vaccines

Current Challenges in CGT Manufacturing

Cell and gene therapies (CGTs) have gained increasing traction over recent years, as they address significant unmet clinical needs such as cancer therapies and rare genetic diseases. The hope for CGTs is that they not only become novel therapies for diseases with little to no treatment options, but also that they become curative, enabling replacement of life-long treatments of chronic conditions.

Focal Molography in a Pandemic

After over a year and a half, the COVID-19 pandemic is still ongoing and is showing no signs of slowing down. It has proven that despite the development of our world on all fronts, we were ill-equipped to handle a pandemic. Somehow, it feels as though we have been one step behind the SARS-CoV-2 virus since the beginning. Although our battle with the virus isn’t over yet, there is a light at the end of the tunnel